HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COMMON STOCK-FO
Total 13F shares
199,805,216
Share change
-674,617
Total reported value
$18,384,399,146
Put/Call ratio
74%
Price per share
$92.04
Number of holders
505
Value change
-$30,110,453
Number of buys
269
Number of sells
247

Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q1 2021

As of 31 Mar 2021, HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by 505 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 199,805,216 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Avoro Capital Advisors LLC, PAULSON & CO. INC., JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC. This page lists 505 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.